Touyun Biotech Group (HKSE:01332) Debt-to-Equity : 1.98 (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Debt-to-Equity?

Touyun Biotech Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$154.9 Mil. Touyun Biotech Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$212.7 Mil. Touyun Biotech Group's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$185.5 Mil. Touyun Biotech Group's debt to equity for the quarter that ended in Jun. 2023 was 1.98.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Touyun Biotech Group's Debt-to-Equity or its related term are showing as below:

HKSE:01332' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.44 Max: 1.98
Current: -453.9

During the past 13 years, the highest Debt-to-Equity Ratio of Touyun Biotech Group was 1.98. The lowest was 0.01. And the median was 0.44.

HKSE:01332's Debt-to-Equity is not ranked
in the Packaging & Containers industry.
Industry Median: 0.45 vs HKSE:01332: -453.90

Touyun Biotech Group Debt-to-Equity Historical Data

The historical data trend for Touyun Biotech Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Debt-to-Equity Chart

Touyun Biotech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.48

0.46

0.68

1.50

-453.90

Touyun Biotech Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.68	0.94	1.50	1.98	-453.90

Competitive Comparison of Touyun Biotech Group's Debt-to-Equity

For the Packaging & Containers subindustry, Touyun Biotech Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Touyun Biotech Group's Debt-to-Equity Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Debt-to-Equity falls into.

Touyun Biotech Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Touyun Biotech Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(200.822	+	194.192)	/	263.959
	=	1.50

Touyun Biotech Group's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(154.878	+	212.73)	/	185.494
	=	1.98

Touyun Biotech Group (HKSE:01332) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Touyun Biotech Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Touyun Biotech Group (HKSE:01332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG

Website

https://www.touyunbiotech.com.hk

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines